{"id":"https://openalex.org/W2741783128","doi":"https://doi.org/10.1158/1538-7445.am2017-3637","title":"Abstract 3637: Co-targeting of PD-1 and CTLA-4 inhibitory pathways with bispecific DART\u00ae and TRIDENT\u2122 molecules","display_name":"Abstract 3637: Co-targeting of PD-1 and CTLA-4 inhibitory pathways with bispecific DART\u00ae and TRIDENT\u2122 molecules","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2741783128","doi":"https://doi.org/10.1158/1538-7445.am2017-3637","mag":"2741783128"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-3637","doi":"https://doi.org/10.1158/1538-7445.am2017-3637","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-3637","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065317972","display_name":"Gurunadh Reddy Chichili","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gurunadh R. Chichili","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109035942","display_name":"Kalpana Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kalpana Shah","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072006697","display_name":"Ross N. La Motte-Mohs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ross La Motte-Mohs","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065336138","display_name":"Alex Berezhnoy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Berezhnoy","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082049590","display_name":"Daorong Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daorong Liu","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jessica Hill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Hill","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Leilei He","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leilei He","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022666141","display_name":"Christine A. Shoemaker","orcid":"https://orcid.org/0000-0003-0895-0361","observed_orcids":["https://orcid.org/0000-0003-0895-0361"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Shoemaker","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003086828","display_name":"Jennifer G. Brown","orcid":"https://orcid.org/0000-0001-7149-1546","observed_orcids":["https://orcid.org/0000-0001-7149-1546"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Brown","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020324790","display_name":"Kurt Stahl","orcid":"https://orcid.org/0009-0001-7230-6856","observed_orcids":["https://orcid.org/0009-0001-7230-6856"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kurt Stahl","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100344259","display_name":"Hua Li","orcid":"https://orcid.org/0000-0003-2153-2500","observed_orcids":["https://orcid.org/0000-0003-2153-2500","https://orcid.org/0009-0008-9698-2956"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hua Li","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100613895","display_name":"Jonathan Li","orcid":"https://orcid.org/0000-0002-8004-0015","observed_orcids":["https://orcid.org/0000-0002-8004-0015"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Li","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056696051","display_name":"Sergey N. Gorlatov","orcid":"https://orcid.org/0000-0002-1430-8765","observed_orcids":["https://orcid.org/0000-0002-1430-8765"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sergey Gorlatov","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022344796","display_name":"Jim Tamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jim Tamura","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061388073","display_name":"Valentina C. Ciccarone","orcid":"https://orcid.org/0000-0001-5530-7112","observed_orcids":["https://orcid.org/0000-0001-5530-7112"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Valentina Ciccarone","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110185766","display_name":"Ralph F. Alderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ralph Alderson","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009027578","display_name":"Ezio Bonvini","orcid":"https://orcid.org/0000-0001-9054-3137","observed_orcids":["https://orcid.org/0000-0001-9054-3137"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ezio Bonvini","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023294934","display_name":"Paul A. Moore","orcid":"https://orcid.org/0000-0001-6057-7539","observed_orcids":["https://orcid.org/0000-0001-6057-7539"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul A. Moore","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031117799","display_name":"Syd Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Syd Johnson","raw_affiliation_strings":["MacroGenics, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210106297"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"3637","last_page":"3637"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.859000027179718},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":1.0},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8790000081062317},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.902999997138977},{"id":"https://openalex.org/keywords/pd-1-pd-l1-interaction","display_name":"PD-1/PD-L1 interaction","score":0.7129999995231628},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.6779999732971191},{"id":"https://openalex.org/keywords/avidity","display_name":"avidity","score":0.6259999871253967},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6650000214576721},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7139999866485596},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.7039999961853027},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9929999709129333}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5646140575408936},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.5409489870071411},{"id":"https://openalex.org/C2778556491","wikidata":"https://www.wikidata.org/wiki/Q1660173","display_name":"Immunoconjugate","level":4,"score":0.5140055418014526},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.443869948387146},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.4388028085231781},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.43620383739471436},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.4108502268791199},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.38961344957351685},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.37468501925468445},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.36659660935401917},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2998042404651642},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27927857637405396},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2745133638381958},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2037653625011444},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.19784247875213623},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.18799644708633423},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.1745125949382782},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-3637","doi":"https://doi.org/10.1158/1538-7445.am2017-3637","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-3637","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3115547163","https://openalex.org/W2493103202","https://openalex.org/W7163694823","https://openalex.org/W3087106203","https://openalex.org/W4404827454","https://openalex.org/W3043895034","https://openalex.org/W2885128417","https://openalex.org/W3212518782","https://openalex.org/W2947821018","https://openalex.org/W4388079291"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Immunotherapy":[2],"with":[3,24,189,270,343,366,376,460],"the":[4,81,216,224,250,262,271,275,308,313,344,347,367,385,470],"combination":[5,345],"of":[6,44,141,186,197,215,239,244,274,292,312,346,387,399,454,469],"monoclonal":[7],"antibodies":[8],"(mAbs)":[9],"that":[10,22,109,210,281,302,339,341],"block":[11,361],"PD-1":[12,31,52,61,67,74,95,103,121,142,180,187,218,293,305,353,362,388,401,455],"(nivolumab)":[13],"and":[14,62,64,122,126,143,170,242,286,294,329,357,363,456,463],"CTLA-4":[15,33,54,69,88,105,123,144,235,267,276,310,355,364,382,403,457],"(ipilimumab)":[16],"has":[17],"shown":[18,297],"clinical":[19],"benefit":[20],"beyond":[21],"observed":[23,342],"either":[25],"mAb":[26,124],"alone.":[27],"We":[28],"have":[29],"developed":[30],"x":[32,53,68,354,402],"bispecific":[34,55,359,400,461],"proteins":[35,172,288,331],"aimed":[36],"at":[37],"inducing":[38],"antitumor":[39],"immunity":[40],"through":[41,90,304],"simultaneous":[42],"blockade":[43,89,106,383],"both":[45,60,99,113,206,283,317,327],"checkpoint":[46],"molecules.":[47,114],"Two":[48],"proteins,":[49],"a":[50,65,228,333,371],"tetravalent":[51],"DART\u00ae":[56,462],"protein":[57,71,83,226,264,369],"(bivalent":[58,72],"for":[59,73,77,307,405,473],"CTLA-4)":[63,78],"trivalent":[66],"TRIDENT\u2122":[70,464],"but":[75],"monovalent":[76,272],"were":[79,117,133,211],"engineered;":[80],"TRIDENT":[82,171,254,287,314,330,358,368],"was":[84,145,155],"designed":[85],"to":[86,94,213,222,234,249,380],"promote":[87],"avidity":[91,311],"when":[92,316],"bound":[93],"on":[96],"cells":[97,108,280],"co-expressing":[98],"receptors,":[100,284],"thus":[101],"favoring":[102],"over":[104],"in":[107,147,157,176,232,265,279,323,336,384],"do":[110],"not":[111],"co-express":[112,282],"Methods:":[115],"Proteins":[116],"engineered":[118],"from":[119],"humanized":[120],"sequences":[125],"demonstrated":[127],"favorable":[128],"biophysical":[129],"properties.":[130],"Binding":[131],"assays":[132],"performed":[134],"by":[135,298],"ELISA":[136],"or":[137,164,181,191],"flow":[138],"cytometry.":[139],"Co-ligation":[140],"assessed":[146],"an":[148],"enzyme-fragment":[149,299],"complementation":[150],"assay":[151],"(DiscoverX).":[152],"T-cell":[153,200,245,324,394],"activation":[154,395],"tested":[156],"reporter":[158],"cells,":[159,237],"staphylococcus":[160],"enterotoxin":[161],"B-stimulated":[162],"PBMCs":[163],"MLR":[165],"assays.":[166],"Results:":[167],"Both":[168,352,390],"DART":[169,225,263,285,328,356],"showed":[173,208,227,257,332,392],"equivalent":[174],"potency":[175,230,260],"binding":[177,233,373],"immobilized":[178],"recombinant":[179],"PD-1-expressing":[182],"cell":[183],"lines,":[184],"inhibition":[185,238,247],"interaction":[188,241],"PD-L1":[190],"PD-L2":[192],"as":[193,195,296],"well":[194],"reversal":[196,243],"PD-1/PD-L1":[198],"mediated":[199],"signal":[201,246],"inhibition.":[202],"In":[203],"all":[204,266],"assays,":[205,268,326],"formats":[207],"activities":[209],"comparable":[212,290,334,393],"those":[214],"precursor":[217,251],"mAb.":[219,252],"With":[220],"respect":[221],"CTLA-4,":[223,295],"minor":[229],"loss":[231],"expressing":[236],"CTLA-4/B7":[240],"compared":[248],"The":[253],"protein,":[255],"however,":[256],"substantial":[258],"lower":[259],"than":[261],"consistent":[269,375],"nature":[273],"arm.":[277],"Importantly,":[278],"show":[289],"co-engagement":[291],"complementation,":[300],"suggesting":[301],"anchoring":[303],"compensates":[306],"decreased":[309],"molecule":[315],"target":[318],"receptors":[319],"are":[320],"expressed.":[321],"Similarly,":[322],"co-activation":[325],"increase":[335],"IFN-gamma":[337],"response":[338],"recapitulated":[340],"individual":[348],"parental":[349],"mAbs.":[350],"Conclusion:":[351],"molecules":[360,391,404,465],"pathways,":[365],"demonstrating":[370],"PD-1-biased":[372],"preference,":[374],"its":[377],"design":[378],"intended":[379],"reduce":[381],"absence":[386],"co-expression.":[389],"activity.":[396],"Further":[397],"development":[398],"cancer":[406],"treatment":[407],"is":[408],"warranted.":[409],"Citation":[410],"Format:":[411],"Gurunadh":[412],"R.":[413],"Chichili,":[414],"Kalpana":[415],"Shah,":[416],"Ross":[417],"La":[418],"Motte-Mohs,":[419],"Alex":[420],"Berezhnoy,":[421],"Daorong":[422],"Liu,":[423],"Jessica":[424],"Hill,":[425],"Leilei":[426],"He,":[427],"Christine":[428],"Shoemaker,":[429],"Jennifer":[430],"Brown,":[431],"Kurt":[432],"Stahl,":[433],"Hua":[434],"Li,":[435,437],"Jonathan":[436],"Sergey":[438],"Gorlatov,":[439],"Jim":[440],"Tamura,":[441],"Valentina":[442],"Ciccarone,":[443],"Ralph":[444],"Alderson,":[445],"Ezio":[446],"Bonvini,":[447],"Paul":[448],"A.":[449],"Moore,":[450],"Syd":[451],"Johnson.":[452],"Co-targeting":[453],"inhibitory":[458],"pathways":[459],"[abstract].":[466],"In:":[467],"Proceedings":[468],"American":[471],"Association":[472],"Cancer":[474,487],"Research":[475],"Annual":[476],"Meeting":[477],"2017;":[478],"2017":[479],"Apr":[480],"1-5;":[481],"Washington,":[482],"DC.":[483],"Philadelphia":[484],"(PA):":[485],"AACR;":[486],"Res":[488],"2017;77(13":[489],"Suppl):Abstract":[490],"nr":[491],"3637.":[492],"doi:10.1158/1538-7445.AM2017-3637":[493]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2017-08-08T00:00:00"}